Analysguiden inleder bevakning på det havsbaserade vindkraftbolaget Hexicon.
Concejo fortsätter att aktivt utvecklas som ett blandat investmentbolag.
Carlsquare Equity Research initierar bevakning av Candles Scandinavia.
Redeye leaves a comment following Egetis therapeutics’ announcement earlier this morning of a SEK 18...
Redeye comments on Lipigon’s successful identification of new small molecules that activate lipoprot...
Tidigare idag annonserade Irlab en ny läkemedelskandidat, IRL757, med fokus på apati inom neurologis...
Metacon är ett energiteknikbolag med produkter som adresserar den växande vätgasmarkanden, som efter...
Jettys omvända förvärv av Nowa Kommunikation har skapat en växande företagsgrupp inom PR, media, rek...
On 18 March, Cibus announced the terms of the class D share bonus issue.
Redeye regards this morning’s news about the regulatory submission of the North American phase 3 stu...
Redeye states that last night’s oral hearing involved reinstated hope in surviving the ‘993 IPR thro...
We give a short comment on the progress in Nanexa's patent infringement case.
Redeye endorses ISAB signing yet another IRS contract worth around SEK 773,000 (EUR 74,000).
Tillväxt i Q4 Omsättningen för Q4 uppgick till EUR 6,6 m (6,4 m) vilket var 2% över våra estimat om ...
Redeye leaves its Base Case unchanged following Infracom’s Q4 report, implying significant upside po...
Redeye initiates coverage of Binero, a B2B cloud and platform provider based on open source, data in...
Redeye comments on Energy Save’s Q3’21/22 report. The report showed strong growth and profitability ...
Inzile has received its first order for electric vehicles within the joint venture with Pinero Group...
Scandinavian Medical Solutions A/S (“SMS” or the “Company”) is a broker, specialized in the purchase...
Today, 17 March 2022, Hanza Holding held a presentation for German institutional investors.
